Transcription-directed payloads interfere with the machinery that makes RNA. Antibody delivery is being studied to limit exposure, but each design needs evidence of useful activity and tolerability.
Transcription inhibition interrupts RNA production, unlike TOP1 poisons or tubulin inhibitors. Amanitin directly inhibits RNA polymerase II; triptolide interferes with the transcription factor TFIIH. The HDP-101 preclinical study included proliferating and resting myeloma cells. That result does not establish activity against every dormant tumor or clinical resistance mechanism. Targeted delivery, intracellular activity and tolerability must be demonstrated for each construct.
In plain words · POLR2A encodes the largest subunit of RNA polymerase II, which makes RNA from DNA. Researchers study whether losing one gene copy creates a vulnerability to further suppression.
Showing the target this term concerns: POLR2A.
Shares Next-generation antibody-conjugate payloads, Payload (ADC), Antibody-drug conjugate (ADC).
Shares Next-generation antibody-conjugate payloads, Payload (ADC), Antibody-drug conjugate (ADC).
Shares Next-generation antibody-conjugate payloads, Payload (ADC), Antibody-drug conjugate (ADC).
Shares Next-generation antibody-conjugate payloads, Payload (ADC), Antibody-drug conjugate (ADC).
Shares Next-generation antibody-conjugate payloads, Payload (ADC), Antibody-drug conjugate (ADC).
Shares Next-generation antibody-conjugate payloads, Payload (ADC), Antibody-drug conjugate (ADC).
Shares Next-generation antibody-conjugate payloads, Payload (ADC), Antibody-drug conjugate (ADC).
Shares Next-generation antibody-conjugate payloads, Payload (ADC), Antibody-drug conjugate (ADC).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/